However, taking into consideration the extremely low incidence of p21 mutations in human cancer and the less drastic tumor-prone phenotype in p21-deficient mice in comparison to mice deficient in other tumor suppressors, such as p53 or p16, the tumor suppressive role of p21 is not viewed as crucial. This evidence concerns the gene CDKN1A and neoplasm.